Effects of recombinant human interferon β1a on the chondrogenic differentiation of human bone marrow mesenchymal stem cell.
- Author:
Qiaoqiao LI
1
;
Lijun ZHANG
2
;
Zhili HUANG
2
;
Fei WANG
1
;
Zhenqiang WU
1
;
Yan WANG
2
Author Information
- Publication Type:Journal Article
- Keywords: TGF-β3; chondrogenic differentiation; hMSCs; recombinant human interferon beta 1a
- From: Chinese Journal of Biotechnology 2018;34(6):964-972
- CountryChina
- Language:Chinese
- Abstract: Recombinant human interferon beta (rhIFN-β) is a glycoprotein produced by genetically engineered cells and has anti-virus, anti-tumor and immunoregulation functions. Although studies have shown that other subtypes of IFN such as IFN-γ affects cell proliferation and differentiation to some extent, the effect of rhIFN-β on chondrogenic differentiation of human bone marrow mesenchymal stem cells (hMSCs) is less known. In this study we studied the effect of rhIFN-β on the chondrogenic differentiation of hMSCs by inducing hMSCs into cartilage pellet via adding IFN-β1a into regular TGF-β3 chondrogenic differentiation medium. We collected the induced pellets and then detected GAG content, assessed pellets size, observed agreecan using alcian blue staining, and analyzed the expression of Sox and CollangenⅡusing real-time PCR and Western blotting. Addition of 100 ng/mL IFN-β1a to regular TGF-β3 chondrogenic differentiation medium could improve the concentration of GAG, increase the size of pellets, promote the formation of aggrecan and up-regulate the expression of CollangenII and Sox9. IFN-β1a combined with TGF-β3 could promote chondrogenic differentiation of hMSCs.
